INFARMED changes medicines for export

INFARMED changes medicines for export

The list of controlled medicines whose export or distribution in the EU requires prior notification to INFARMED was updated by Resolution No. 086/CD/2024 of August 9, 2024. The changes to Annex I of the Regulation on Prior Notification of Medicines Transactions will be reflected in the SiExp platform. Read more here

If you need more information on regulatory issues, ELS can certainly help.

Please do not hesitate to contact your local ELS consultant or via email info@elssolutions.pt

ELS Group

ELS Group brings together a team of highly specialized professionals with proven experience in regulatory frameworks and compliance in the pharmaceutical field.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.

Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.

Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.